Literature DB >> 20525412

Emergence of group B Streptococcus serotype IV in women of child-bearing age in Ireland.

R A Kiely1, L Cotter, A M Mollaghan, B Cryan, A Coffey, B Lucey.   

Abstract

This study determined the carriage rate and serotype distribution of group B Streptococcus (GBS) in women of child-bearing age in the southern region of Ireland. A total of 2000 vaginal swabs collected in two periods in 2004 and 2006 were examined and revealed a GBS carriage rate of 16·1%. Serotyping of isolates showed that serotypes Ia, II, III, IV, and V were the most prevalent. A high prevalence of serotype IV was found, increasing from 7·6% to 15·2% between 2004 and 2006. Random amplified polymorphic DNA analysis demonstrated considerable genetic heterogeneity in the serotype IV isolates. This serotype should be considered for inclusion in potential vaccines for use in Ireland.

Entities:  

Mesh:

Year:  2010        PMID: 20525412     DOI: 10.1017/S0950268810001275

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  7 in total

1.  Identification of Group B Streptococcus Capsule Type by Use of a Dual Phenotypic/Genotypic Assay.

Authors:  Areej Alhhazmi; Armaan Pandey; Gregory J Tyrrell
Journal:  J Clin Microbiol       Date:  2017-06-14       Impact factor: 5.948

2.  Emergence of Serotype IV Group B Streptococcus Adult Invasive Disease in Manitoba and Saskatchewan, Canada, Is Driven by Clonal Sequence Type 459 Strains.

Authors:  Sarah Teatero; Taryn B T Athey; Paul Van Caeseele; Greg Horsman; David C Alexander; Roberto G Melano; Aimin Li; Anthony R Flores; Samuel A Shelburne; Allison McGeer; Walter Demczuk; Irene Martin; Nahuel Fittipaldi
Journal:  J Clin Microbiol       Date:  2015-07-01       Impact factor: 5.948

3.  Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.

Authors:  Mary Meehan; Robert Cunney; Mary Cafferkey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-28       Impact factor: 3.267

4.  Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013.

Authors:  Areej Alhhazmi; Donna Hurteau; Gregory J Tyrrell
Journal:  J Clin Microbiol       Date:  2016-04-20       Impact factor: 5.948

5.  Population structure and antimicrobial resistance of invasive serotype IV group B Streptococcus, Toronto, Ontario, Canada.

Authors:  Sarah Teatero; Allison McGeer; Aimin Li; Janice Gomes; Christine Seah; Walter Demczuk; Irene Martin; Jessica Wasserscheid; Ken Dewar; Roberto G Melano; Nahuel Fittipaldi
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

6.  Group B Streptococcus colonization at delivery is associated with maternal peripartum infection.

Authors:  Anne Karin Brigtsen; Anne Flem Jacobsen; Lumnije Dedi; Kjetil Klaveness Melby; Cathrine Nygaard Espeland; Drude Fugelseth; Andrew Whitelaw
Journal:  PLoS One       Date:  2022-04-01       Impact factor: 3.240

7.  Multistate, Population-Based Distributions of Candidate Vaccine Targets, Clonal Complexes, and Resistance Features of Invasive Group B Streptococci Within the United States, 2015-2017.

Authors:  Lesley McGee; Sopio Chochua; Zhongya Li; Saundra Mathis; Joy Rivers; Benjamin Metcalf; Alison Ryan; Nisha Alden; Monica M Farley; Lee H Harrison; Paula Snippes Vagnone; Ruth Lynfield; Chad Smelser; Alison Muse; Ann R Thomas; Stephanie Schrag; Bernard W Beall
Journal:  Clin Infect Dis       Date:  2021-03-15       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.